Adult female acne: a new paradigm

Adult female acne: a new paradigm

Author Dreno, B. Google Scholar
Layton, A. Google Scholar
Zouboulis, C. C. Google Scholar
Lopez-Estebaranz, J. L. Google Scholar
Zalewska-Janowska, A. Google Scholar
Bagatin, Edileia Autor UNIFESP Google Scholar
Zampeli, V. A. Google Scholar
Yutskovskaya, Y. Google Scholar
Harper, J. C. Google Scholar
Institution Univ Hosp Hotel Dieu
Harrogate & Dist NHS Fdn Trust
Dessau Med Ctr
Hosp Univ Fdn Alcorcon
Med Univ Lodz
Universidade Federal de São Paulo (UNIFESP)
Vladivostok State Med Univ
Univ Alabama Birmingham
Abstract In the adult female, acne is a chronic condition with a substantial negative psychological, social and emotional impact. Based on time of onset, two subtypes of adult female acne are recognized: 'persistent acne' is a continuation of the disease from adolescence, while 'late-onset acne' first presents in adulthood. the morphological characteristics of adult female acne are often distinct from adolescent acne. in adults, inflammatory lesions (particularly papules, pustules and nodules) are generally more prominent on the lower chin, jawline and neck, and comedones are more often closed comedones (micro cysts). Adult acne is mainly mild-to-moderate in severity and may be refractory to treatment. A holistic approach to acne therapy should be taken in adult females, which combines standard treatments with adjunctive therapy and cosmetic use. A number of factors specific to the adult female influence choice of treatment, including the predisposition of older skin to irritation, a possible slow response to treatment, a high likelihood of good adherence, whether of child-bearing age, and the psychosocial impact of the disease. Adherence to therapy should be encouraged through further patient education and a simplified regimen that is tailored to suit the individual patient's needs and lifestyle. This article reviews the specific characteristics of adult female acne, and provides recommendations for acne therapy in this patient group.
Language English
Sponsor Bayer HealthCare
Date 2013-09-01
Published in Journal of the European Academy of Dermatology and Venereology. Hoboken: Wiley-Blackwell, v. 27, n. 9, p. 1063-1070, 2013.
ISSN 0926-9959 (Sherpa/Romeo, impact factor)
Publisher Wiley-Blackwell
Extent 1063-1070
Access rights Closed access
Type Review
Web of Science ID WOS:000322317400001

Show full item record


File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)




My Account